Genelux Corporation (GNLX) Earnings Per Share (EPS)
Genelux Corporation (GNLX) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2023-12-31 | -$1.16 |
| 2024-12-31 | -$0.95 |
| 2025-12-31 | -$0.86 |
How GNLX compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | -$0.70 |
| GOSS | Gossamer Bio Inc. | -$0.75 |
| EOLS | Evolus Inc. | -$0.80 |
| ALLO | Allogene Therapeutics Inc. | -$0.87 |
| ALT | Altimmune Inc. | -$1.00 |
These are five companies in the same sector as GNLX with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Genelux Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("GNLX")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | GNLX | $2.60 | -3.70% | 0.38M |
| 3 | ||||
| 4 | ||||
| 5 |